The leading players in the global cardiopulmonary stress testing systems market are Spacelabs Healthcare, GE Healthcare, Philips Healthcare, and CareFusion Corporation. These players jointly held a share of 53.5% in 2014, observes Transparency Market Research in its new publication. These players have a vast scope for growth as several developing regions in the world are increasing their healthcare budgets. Thus, research suggests that players must focus on investing in developing economies of South Africa, Brazil, India, and China in the near future. Companies could also benefit from the rising disposable incomes in these countries and the increasing awareness about susceptibility to cardiovascular and pulmonary disorders due to changing lifestyles and poor dietary patterns.
The research report states that the global cardiopulmonary stress testing systems market will be worth US$6.67 bn by 2023 as compared to US$3.30 bn in 2014. Between 2015 and 2023, the overall market is expected to expand at a CAGR of 8.20%. The global market is expected to be led by cardiopulmonary exercise testing (CPET) systems as the incidences of cardiac disorders remain on the rise. The research indicates that this segment will expand at a CAGR of 8.5% between 2015 and 2023. Geographically, North America cardiopulmonary stress testing systems market will rise at a strong CAGR of 7.3%.
Growing Cases of Cardiac Disorders Worldwide Fuel Market Growth
The high incidence of cardiovascular diseases has been the primary factor driving the demand for cardiopulmonary stress testing systems. According to the World Health Organization (WHO), the coronary artery diseases (CADs) account for nearly 64% of the all the deaths due to cardiovascular conditions. Thus this has been identified as the key cause for a poor quality of life for the majority of women and men across the world. Owing to these reasons the demand for cardiopulmonary stress testing systems has considerably risen in the past few years.
The rise in the geriatric population across the world and the growing problem of obesity have also resulted in a sudden uptake of cardiopulmonary stress testing systems. The aged and the obese are both prone to the risk of coronary artery diseases (CADs), which has had a positive impact on the global market in recent years. Technological advancements, rising disposable incomes, growing awareness about possibilities to treat cardiovascular diseases, and penetration of modern monitoring technology have also resulted in a higher diagnoses rate, which has boosted the demand for cardiopulmonary stress testing systems.
Need to Contain Costs Discourages Hospitals from Investing in Modern Equipment
The enactment of laws such as the Affordable Care Act has been urging the healthcare sector for cost containment to provide affordable healthcare to patients. This trend has been hampering the global market to a severe degree. The reduction in healthcare budgets has prompted large hospitals and private firms to invest less in new equipment and systems to be able to offer an affordable healthcare platform in the longer run. Furthermore, exposure to harmful radiation to due to single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) systems has also discouraged the sales of these systems in the recent past.
“The improving healthcare infrastructure of developing countries presents a lucrative growth opportunity to the players in the cardiopulmonary stress testing systems market,” states the lead author of this research report. The expanding business of healthcare insurance, changing lifestyles, and improving purchasing power of consumers will present remarkable opportunities to the overall market in the near future.
The aforementioned review is based Transparency Market Research’s research report, titled “Cardiopulmonary Stress Testing Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”.
- Global cardiopulmonary stress testing systems market to reach US$6.67 bn by 2023
- Cardiopulmonary exercise testing (CPET) systems to rise at 8.5% CAGR on account of increasing cases of cardiac diseases
- North America cardiopulmonary stress testing systems market flourishes as the region embraces technological advancements
The global Cardiopulmonary Stress Testing Systems market is segmented as follows:
Global Cardiopulmonary Stress Testing Systems Market, by Product Type
- Cardiopulmonary Exercise Testing (CPET) Systems
- Portable CPET Systems
- Desktop CPET Systems
- Stress ECG
- Pulse Oximeters
- Stress Blood Pressure Monitors
Global Cardiopulmonary Stress Testing Systems Market, by Geography
- North America
- Rest of Europe
- Rest of Asia Pacific
- Latin America (LATAM)
- Rest of LATAM
- Middle East and North Africa
- Saudi Arabia
- Rest of MENA
- Rest of the World (RoW)
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453